Auriga Research Pvt. Ltd. is currently exhibiting in the CPhI China 2017 at Booth Number E3F45, Hall E3 with the local partner of China to showcase its capabilities and facilities for BA / BE Studies and other technical support to pharmaceutical formulations as well as API Industries. As a Multi-Disciplinary Contract Research and Testing Organization, Auriga has a DCGI approved center for conducting BA/BE studies, and is one of only eight BE centers in India having approval from NPCB, Malaysia.
Auriga is dedicatedly focused on bringing up the highest quality clinical research services with flexible tailored solutions with punctuality & cost effectiveness.
Auriga has a well-established analytical division which is backed by cutting edge technology and a team of 400 professionals in the company which includes medical doctors, pharmacologists, pharmacists, chemists, biotechnologists, food technologists, scientists and management professionals.
Contract Research and Testing partner (Services Offered)
- Bioequivalence Studies
- Analytical Method Development and Validation
- Stability Studies
- Impurity Profiling
- Solid State Characterization
- Technical Training and Development
Auriga Research Pvt. Ltd. has 5 state of art analytical laboratories and two Bioequivalence centers with 80 and 30 bedded facilities. Most of the Analytical Laboratories are ISO / IEC 17025: 2005 accredited through NABL in India. Auriga is one of the few pioneer research and development service providers that offer end-to-end complete solutions for pharmaceutical, biotechnology, food and medical device industries globally.
Auriga Research Pvt. Ltd. is a group venture of ARBRO having more than 30 years of experience in the pharmaceuticals and biotechnology industry serving the organizations around the world.
Come & Visit for the technical discussion with our Managing Director Dr. Saurabh Arora along with Dr. Manoj Karwa (Head – Clinical Trials) and to explore scope of our mutual co-operation.